SinoTruss

Sophisticated, yet simple

Sinotruss is a development stage product and not commercially available in the United States. SinoTruss has not been tested or evaluated by the United States Food and Drug Administration and are not intended for clinical or diagnostic use at this time.

SinoTruss Advantage

The SinoTruss family of devices are made of pure chitosan. These tubular-shaped stents are intended for placement in the sinus openings after surgery to enlarge them. Different sizes are available for the different sinuses, and to accommodate different clinical situations. These stents not only mechanically maintain the sinus drainage pathway during healing, but the chitosan has been shown reduce bleeding and infection. They are designed to dissolve within 3-4 weeks after surgery with routine postoperative nasal saline rinsing.

Why Choose SinoTruss

Sinus Stenting

Surgically-created sinus openings are mechanically held open during the healing period.

Bioabsorbable

The painful removal of alternative types of splints or packing material is eliminated. The SinoTruss residue is easily flushed out of the nostrils.

Hemostatic

Chitosan has been shown to reduce bleeding and promote wound healing.*

Antimicrobial

Chitosan can confer resistance to bacterial and viral infections.*

Search our database to find a provider near you

SinoTruss Difference

SinoTruss Stent

Ventilation/Drainage Optimization

Maintains patency.
Dissolvable

No removal Necessary.
Hemostatic

Chitosan can reduce bleeding.*
Antimicrobial

Chitosan can confer resistance to infection.*

Traditional Nasal Packing

Uncomfortable

Solid & rigid design.
Non-dissolvable

Painful removal required after surgery.
Harder Recovery

Obstructed airways, difficult irrigations, antibiotics necessary to prevent infections.